Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1) : a randomised. double-blind, placebo-controlled, dose-escalation trial

収録刊行物

• Lancet

  Lancet 376 1467-1475, 2010